Bayer Shares Surge as Partner Forecasts Sales Growth for Prostate-Cancer Drug

Date:




Orion predicted strong growth for darolutamide, the prescription prostate-cancer medication it co-developed with Bayer.



Source link

Share post:

Subscribe

spot_imgspot_img

Popular

More like this
Related

Eni Shareholders Set for Cash Boost After Earnings Double

The company kicked off earnings season for energy majors...

Hegseth staff damaged historic WWII-era Eisenhower globe trying to move it to his office

Defense Secretary Pete Hegseth’s staffers damaged a historic globe...

More severe storms Friday before another round of heavy weekend rain

A powerful storm system continues to bring heavy rain...